Pacira BioSciences, Inc. (NASDAQ: PCRX) is a leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com. To learn more about EXPAREL® visit www.exparel.com.
Brands: 1. EXPAREL® (bupivacaine liposome injectable suspension)